Cited by 490Advanced Glycation End Products researchPotato Plant ResearchGenetics, Aging, and Longevity in Model Organisms

Does accumulation of advanced glycation end products contribute to the aging phenotype?

Open access
Semba, R. D., Nicklett, E. J., Ferrucci, L.·2010·The Journals of Gerontology Series A: Biological Sciences and Medical Sciences

Abstract

BACKGROUND: Aging is a complex multifactorial process characterized by accumulation of deleterious changes in cells and tissues, progressive deterioration of structural integrity and physiological function across multiple organ systems, and increased risk of death. METHODS: We conducted a review of the scientific literature on the relationship of advanced glycation end products (AGEs) with aging. AGEs are a heterogeneous group of bioactive molecules that are formed by the nonenzymatic glycation of proteins, lipids, and nucleic acids. RESULTS: Humans are exposed to AGEs produced in the body, especially in individuals with abnormal glucose metabolism, and AGEs ingested in foods. AGEs cause widespread damage to tissues through upregulation of inflammation and cross-linking of collagen and other proteins. AGEs have been shown to adversely affect virtually all cells, tissues, and organ systems. Recent epidemiological studies demonstrate that elevated circulating AGEs are associated with increased risk of developing many chronic diseases that disproportionally affect older individuals. CONCLUSIONS: Based on these data, we propose that accumulation of AGEs accelerate the multisystem functional decline that occurs with aging, and therefore contribute to the aging phenotype. Exposure to AGEs can be reduced by restriction of dietary intake of AGEs and drug treatment with AGE inhibitors and AGE breakers. Modification of intake and circulating levels of AGEs may be a possible strategy to promote health in old age, especially because most Western foods are processed at high temperature and are rich in AGEs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/gerona/glq074

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AGEs have been linked to ageing, chronic illness and death, and they may contribute importantly to frailty.

    “They have been associated with ageing, chronic disease and mortality and may have an important role in frailty (60).”

    From Frailty in elderly people (2013) · cites this paper as [60]

  • Advanced glycation end products form when proteins, lipids and nucleic acids are glycated; they can damage cells widely by increasing inflammation.

    “Advanced glycation end products (AGEs) are a group of molecules produced by the glycation of proteins, lipids and nucleic acid that have potential to cause widespread cellular damage by upregulation of inflammation (60).”

    From Frailty in elderly people (2013) · cites this paper as [60]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Semba RD, Fink JC, Sun K, Windham BG, Ferrucci L. Elevated se- rum advanced glycation end products are associated with renal insuf- ficiency: the Baltimore Longitudinal Study of Aging. J Ren Nutr. 2010;20:74-81.
  2. Schmidt AM, Hasu M, Popov D, et al. Receptor for advanced glyca- tion end products (AGEs) has a central role in vessel wall interac- tions and gene activation in response to circulating age proteins. Proc Natl Acad Sci U S A. 1994;91:8807-8811.
  3. Verzijl N, deGroot J, Ben Zaken C, et al. Crosslinking by advanced glycation end products increases the stiffness of the collagen network in human articular cartilage: a possible mechanism through which age is a risk factor for osteoarthritis. Arthritis Rheum. 2002;46:114-123.

Cited by

Sorted by citations

Authors
Semba, R. D., Nicklett, E. J., & Ferrucci, L.
Affiliations
  • Johns Hopkins University (US)
  • University of Michigan (US)
  • National Institute on Aging (US)
Venue
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
Published
2010-05-17
Volume
65A
Issue
9
Pages
963-975
ISSN
  • 1079-5006 (ISSN-L)
  • 1758-535X
OpenAlex
W2100383922
Cited by
490
References
111
Citations by year
2026: 23 · 2025: 31 · 2024: 31 · 2023: 36 · 2022: 37 · 2021: 32 · 2020: 29 · 2019: 40 · 2018: 35 · 2017: 44 · 2016: 31 · 2015: 31 · 2014: 27 · 2013: 20 · 2012: 23
FWCI
2.06
Type
journal article
Language
en
Open access
Locations
  • The Journals of Gerontology Series A (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r37ag019905-10, NIH-R01, AG027012)
  • National Institute on Aging (R37-AG019905, R01AG027012, R01AG029148)
  • National Heart, Lung, and Blood Institute (R01HL094507)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Potato Plant Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
advanced glycation end products, aging, glycation, inflammation, collagen cross-linking, chronic disease risk, dietary AGEs, AGE inhibitors, glucose metabolism, functional decline in older adults
MeSH terms
Receptor for Advanced Glycation End Products, Aging, Bone and Bones, Brain, Diet, Enzyme Inhibitors, Erythrocytes, Eye, Food Analysis, Guanidines, Humans, Inflammation, Kidney, Liver, Longevity, Myocardium, Receptors, Immunologic, Tendons, Thiazoles, Glycation End Products, Advanced, Oxidative Stress, Muscle, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review